81310-56-7 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(Piperidin-3-ylmethyl)piperidine is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties. Its unique structure allows for the creation of molecules with tailored pharmacological effects.
Used in Agrochemical Synthesis:
In the agrochemical industry, 1-(Piperidin-3-ylmethyl)piperidine is utilized as a building block in the formulation of agrochemicals, potentially enhancing the effectiveness of pesticides, herbicides, and other crop protection agents by providing novel chemical structures.
Used in Organic Synthesis:
1-(Piperidin-3-ylmethyl)piperidine serves as a versatile component in organic synthesis, where it can be employed to construct a range of organic compounds for various applications, including but not limited to, the development of new materials, dyes, and specialty chemicals.
Used in Material Chemistry:
Within the field of material chemistry, 1-(Piperidin-3-ylmethyl)piperidine is used as a component in the design and synthesis of new materials, potentially contributing to advancements in areas such as polymer science, nanotechnology, and the creation of functional materials with specific properties.
The exact applications and benefits of 1-(Piperidin-3-ylmethyl)piperidine in these industries are subject to ongoing research and development, as its full potential is yet to be comprehensively understood and harnessed.
Check Digit Verification of cas no
The CAS Registry Mumber 81310-56-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,3,1 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 81310-56:
(7*8)+(6*1)+(5*3)+(4*1)+(3*0)+(2*5)+(1*6)=97
97 % 10 = 7
So 81310-56-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H22N2/c1-2-7-13(8-3-1)10-11-5-4-6-12-9-11/h11-12H,1-10H2
81310-56-7Relevant academic research and scientific papers
Nencini, Arianna,Castaldo, Cristiana,Comery, Thomas A.,Dunlop, John,Genesio, Eva,Ghiron, Chiara,Haydar, Simon,Maccari, Laura,Micco, Iolanda,Turlizzi, Elisa,Zanaletti, Riccardo,Zhang, Jean
, p. 401 - 418 (2014)
α7 nicotinic acetylcholine receptor agonists are promising therapeutic candidates for the treatment of cognitive impairment. As a follow up of our internal medicinal chemistry program we investigated a novel series of α7 nAChR agonists. Starting from molecular docking studies on two series of molecules recently developed in our laboratories, an alternative scaffold was designed attempting to combine the optimal features of these previously identified urea and pyrazole compounds. Based on our previous SAR knowledge and on predicted drug-like properties, a small library was synthesized in parallel manner, affording compounds with excellent α7 nAChR activity, selectivity and preliminary ADME profile.
